Globally, Higher Daily Consumption of Soft Drinks Tied to Obesity Risk in Teens
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
TUESDAY, July 25, 2023 -- The prevalence of daily consumption of soft drinks is associated with the prevalence of overweight and obesity among adolescent students globally, according to a study published online July 24 in JAMA Network Open.
Huan Hu, Ph.D., from the Research Center for Prevention from Radiation Hazards of Workers at the National Institute of Occupational Safety and Health in Kanagawa, Japan, and colleagues examined the association of soft drink consumption with overweight and obesity in 405,528 adolescents enrolled in school across 107 countries and regions.
The researchers found that the prevalence of overweight and obesity among adolescent students varied from 3.3 percent in Cambodia to 64.0 percent in Niue. Similarly, the prevalence of adolescent students consuming soft drinks one or more times per day varied from 3.3 percent in Iceland to 79.6 percent in Niue, with a positive correlation noted between the prevalence of daily soft drink consumption and the prevalence of overweight and obesity (partial correlation coefficient, 0.44).
"In conjunction with the evidence from prospective cohort studies and randomized trials, our findings support that reducing soft drink consumption should be a prioritized approach for curbing the pandemic of overweight and obesity among adolescents," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
Small Differences in Weight Change With First-Line Antidepressants
MONDAY, July 1, 2024 -- For eight first-line antidepressants, small differences are seen in mean weight change, with the least weight gain with bupropion, according to a study...
Bariatric Surgery Tied to Lower Risk of MACE, Death in Obesity, Sleep Apnea
FRIDAY, June 28, 2024 -- Metabolic surgery is associated with significantly lower risk of major adverse cardiovascular events (MACE) compared with nonsurgical management among...
Exercise + GLP-1 RA Effective for Weight Loss While Preserving BMD
THURSDAY, June 27, 2024 -- For adults with obesity, without diabetes, combining exercise with the glucagon-like peptide-1 receptor agonist (GLP-1 RA), liraglutide, is effective...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.